Nutrition Disorders: Clinical Trials

16,523 trials for Nutrition Disorders, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10342 completed, 2156 unknown, 1544 recruiting, 681 active not recruiting. 9436 Not applicable, 1178 Phase 2, 873 Phase 3, 872 Phase 1, 783 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable9436Completed 6125, Unknown 1211, Recruiting 802, Active not recruiting 377, Not yet recruiting 347, Terminated 301, Withdrawn 185, Enrolling by invitation 72, Suspended 16
Phase 21178Completed 738, Recruiting 105, Unknown 95, Terminated 74, Active not recruiting 61, Withdrawn 51, Not yet recruiting 47, Suspended 4, Enrolling by invitation 3
Phase 3873Completed 509, Recruiting 102, Unknown 91, Terminated 55, Active not recruiting 50, Not yet recruiting 35, Withdrawn 27, Suspended 3, Enrolling by invitation 1
Phase 1872Completed 567, Recruiting 104, Active not recruiting 52, Unknown 45, Not yet recruiting 42, Terminated 39, Withdrawn 20, Suspended 2, Enrolling by invitation 1
Phase 4783Completed 464, Unknown 116, Recruiting 58, Terminated 43, Not yet recruiting 40, Active not recruiting 30, Withdrawn 27, Enrolling by invitation 4, Suspended 1
Early Phase 1154Completed 84, Unknown 23, Recruiting 17, Withdrawn 9, Terminated 7, Active not recruiting 5, Not yet recruiting 5, Suspended 3, Enrolling by invitation 1

Follow Nutrition Disorders: new trials by email Literature Review of Nutrition Disorders trials Research Report on Nutrition Disorders

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluating the Metabolic Effects of Polylactose: A Novel Prebiotic
Polylactose, Placebo - Obesity, Adolescent, Obesity, Childhood
Not applicableWithdrawnUniversity of Minnesota2028-05-012025-07-11
A Study of Body Fat Distribution and Airway Mechanics in Healthy Adults
Body positioning - Healthy Volunteers Only
Not applicableNot yet recruitingMaurizio F. Cereda, MD202028-01-012025-06-18
Adiposity Distribution in Acute Respiratory Failure
PEEP Titration Using Electrical Impedance Tomography (EIT), Body Positioning: Supine and Prone - Acute Hypoxemic Respiratory Failure, Obesity
Not applicableNot yet recruitingMaurizio F. Cereda, MD802028-01-012025-06-13
Community Active and Healthy Families Pragmatic Trial
Community Active and Healthy Families Intensive Health Behavior and Lifestyle Treatment - Child Obesity
Phase 4Not yet recruitingUniversity of Colorado, Denver4162028-01-012026-10-09
Efficacy, Safety, and Treatment Satisfaction of Once-Weekly Tirzepatide in Obese Type 2 Diabetic Patients
Tirzepatide + Standard Therapy (Intervention Group), Standard Oral Antidiabetic Drugs (OADs) - Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight
Not applicableNot yet recruitingAkhtar Saeed Medical and Dental College522027-12-122026-10-29
AI-INFORMED PEER-MENTORING BEHAVIORAL INTERVENTION FOR OBESITY AND CARDIOVASCULAR DISEASE PRIMARY PREVENTION IN YOUTH
AI-informed behavioral intervention, Standard behavioral intervention, Health Education - Obesity (Disorder)
Not applicableNot yet recruitingAikaterini Karaivazoglou8402027-09-012026-04-14
Modifying Diet to Improve Gut Microbiome
DASH diet, standard American diet - Obesity
Not applicableNot yet recruitingH. Lee Moffitt Cancer Center and Research Institute282027-07-012026-09-17
Oxytocin for Respiratory Compromise and Hypoventilation Induced by Drugs
Intranasal Oxytocin 40 i.u., Intranasal Placebo Spray - Obesity & Overweight, Respiratory Depression
Phase 2Not yet recruitingGeorge Washington University1002027-05-152026-10-29
Simplifying Diet Tracking in a Digital Weight Loss Intervention
Simplified Dietary Self-Monitoring, Detailed Dietary Self-Monitoring, Core Behavioral Weight Loss Intervention - Overweight, Obesity
Not applicableNot yet recruitingStanford University3282027-05-012026-05-28
The Effect of Oral Iron Supplements on Insulin and Glucose Metabolism in Overweight and Obese Women
195 mg iron daily, 15 mg iron daily - Overweight and Obese Women
Not applicableRecruitingNicole Stoffel702027-05-012026-11-13
Reflux Disease After Gastric Bypass Versus Sleeve Gastrectomy in Morbid Obese Patients: an Italian Study
Roux-en-Y-Gastric bypass, Sleeve gastrectomy, SG - Gastroesophageal Reflux Disease, Obesity
Not applicableNot yet recruitingNiguarda Hospital1282027-05-012026-11-12
Impact of Endoscopic Sleeve Gastroplasty (ESG) in Obese Adults With Type 2 Diabetes (T2D)
ESG with OverStitch - Type 2 Diabetes Mellitus (T2D), Obesity (BMI>30)
Not applicableNot yet recruitingBoston Scientific Corporation502027-04-012026-11-06
Can Two Dietary Interventions Maintain Weight Loss for 12 Months After GLP-1 Therapy in Adults With Overweight/Obesity?
NutriAct plus, Rescue VLCD - Obesity & Overweight, Weight Loss Maintenance
Not applicableNot yet recruitingKnut Mai2922027-03-012026-07-20
Cardiometabolic Effects of the Recommended Daily Pecan Intake Dose
Pecan, Control - Nutrition, Healthy, Dyslipidemia
Not applicableNot yet recruitingUniversity of Georgia902027-03-012026-08-11
Semaglutide for Weight Management During Hormone Therapy for Early Breast Cancer
Semaglutide (Wegovy®) - Breast Cancer (Early Breast Cancer), Obesity
Phase 2Not yet recruitingAarhus University Hospital322027-03-012026-11-02
Brain and Obesity Longitudinal Development: Neurobiological Mechanisms of Semaglutide Treatment of Adolescent Obesity
Semaglutide - Pediatric Obesity, Obesity
Not yet recruitingErin Mauney122027-03-012026-11-02
Puerto Rican Obesity Intervention for Men
TeleSalud Healthy Eating- Physical Activity/Sedentary Behavior (HE-PA/SB), TeleSalud General Health Intervention - Obesity
Not applicableNot yet recruitingMedical College of Wisconsin482027-03-012026-10-30
A Randomized Controlled Trial of Prepared vs. Unprepared Food
Prepared meals, Unprepared Pantry/Produce box - Pregnant Patients at Risk of Gestational Diabetes
Not applicableNot yet recruitingUniversity of Michigan402027-03-012026-11-12
Evaluating the Efficacy and Safety of LUM-201 Plus Semaglutide Versus Semaglutide Plus Placebo in Older Obese Adults
LUM-201, Placebo, Semagludtide - Obesity & Overweight
Phase 2Not yet recruitingLumos Pharma2022027-02-152026-08-10
BRE-13: Mediterranean Diet
Explore the effect of MedDiet vs. Usual Diet on Fatty Acid Profile, Explore the effect of MedDiet vs. Usual Diet on Breast Tumor Tissue, Explore the effect of MedDiet vs. Usual Diet on Lipids - Dietary Assessment, Dietary and Lifestyle Behaviour Change
Not applicableNot yet recruitingUniversity of Illinois at Chicago302027-02-152026-10-09

Showing 20 of 16523. Sign in to see all of them.

Narrower conditions

Obesity (11411)  ·  Overweight (3576)  ·  Weight Loss (1238)  ·  Malnutrition (1228)  ·  Motor Activity (1192)  ·  Diabetes Mellitus, Type 2 (1155)  ·  Pediatric Obesity (1124)  ·  Obesity, Morbid (934)  ·  Diabetes Mellitus (863)  ·  Insulin Resistance (825)  ·  Vitamin D Deficiency (797)  ·  Metabolic Syndrome (741)  ·  Hypertension (613)  ·  Cardiovascular Diseases (506)  ·  Inflammation (381)

Broader conditions

Nutritional and Metabolic Diseases (16501)  ·  Pathological Conditions, Signs and Symptoms (14438)  ·  Signs and Symptoms (13988)  ·  Overnutrition (13703)  ·  Body Weight (13398)  ·  Overweight (10166)  ·  Metabolic Diseases (3766)  ·  Glucose Metabolism Disorders (3210)  ·  Endocrine System Diseases (2483)  ·  Behavior (2296)  ·  Obesity (1844)  ·  Pathologic Processes (1450)  ·  Body Weight Changes (1441)  ·  Hyperinsulinism (1411)

Interventions

Exercise (517)  ·  Cholecalciferol (340)  ·  Diet (250)  ·  semaglutide (226)  ·  Vitamin D (203)  ·  Bariatric Surgery (164)  ·  Tirzepatide (153)  ·  Nutrition Assessment (137)  ·  Metformin (131)  ·  Liraglutide (127)  ·  Gastric Bypass (117)  ·  Caloric Restriction (112)  ·  Control Groups (110)  ·  Diet Therapy (95)  ·  Standard of Care (94)

Sponsors

Novo Nordisk A/S (206)  ·  University of Colorado, Denver (130)  ·  Washington University School of Medicine (125)  ·  Mayo Clinic (123)  ·  Eli Lilly and Company (118)  ·  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (112)  ·  University of Copenhagen (103)  ·  Massachusetts General Hospital (100)  ·  Maastricht University Medical Center (96)  ·  Pennington Biomedical Research Center (95)  ·  University of Alabama at Birmingham (92)  ·  The Miriam Hospital (91)  ·  Yale University (90)  ·  Duke University (85)  ·  University of Pennsylvania (84)

Countries

United States (6120)  ·  China (774)  ·  Canada (736)  ·  France (721)  ·  United Kingdom (641)  ·  Spain (570)  ·  Turkey (Türkiye) (547)  ·  Italy (488)  ·  Denmark (482)  ·  Germany (447)  ·  Brazil (362)  ·  Netherlands (333)  ·  Egypt (292)  ·  Mexico (281)  ·  Sweden (265)

Top investigators

Samuel Klein, MD (22)  ·  Jack A Yanovski, M.D. (20)

Results publications

PMID 38375882, PMID 33512717, PMID 33305842, PMID 29718281, PMID 38376518, PMID 39077939, PMID 39151033, PMID 26210388, PMID 26708836, PMID 30122305, PMID 30230252, PMID 33238176, PMID 40839263, PMID 41029405, PMID 28386912, PMID 28950422, PMID 30651576, PMID 33782940, PMID 38271099, PMID 42014131, PMID 22085317, PMID 23987123, PMID 24500151, PMID 24570244, PMID 26529632, PMID 26599819, PMID 27474016, PMID 27482610, PMID 27817208, PMID 28473337, PMID 28978680, PMID 31004409, PMID 32002540, PMID 32909523, PMID 33567185, PMID 37652841, PMID 38698650, PMID 39226070, PMID 39952695, PMID 40576086, PMID 40705619, PMID 11832527, PMID 14688154, PMID 15479938, PMID 17715408, PMID 18673303, PMID 19858703, PMID 20573639, PMID 20798995, PMID 21646368

NIH funding

2025 (59), 2023 (38), 2017 (32), 2019 (27), 2018 (22), 2014 (20), 2015 (16), 2016 (16), 2009 (15), 2008 (12), UL1TR001082 (10), P50MD017338 (6), R01DK059853 (6), UL1TR000135 (6), 2005 (5)